1 of 1
Story summary
- Prof. Jacob George, a health official, has been removed from the Pathways puberty blockers trial after bias accusations, triggering a pause.
- The Medicines and Healthcare products Regulatory Agency (MHRA) announced that he would recuse himself following controversial social media posts.
- The trial raised the minimum age for participation from 10–12 to 14 years due to potential long-term risks.
- Experts say there is no scientific reason to halt the trial.
